Putnam BioRevolution ETF Rating $27.08 -0.85 (-3.04%) Closing price 04:10 PM EasternExtended Trading$27.24 +0.16 (+0.59%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsBuy This Stock Putnam BioRevolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy 2.82Holdings in SYNB have an aggregate rating of Moderate Buy based on 584 analyst ratings issued in the past year covering 33 companies (91.6% of the portfolio).SYNB Aggregate Price Target$27.08High Prediction$27.08Average Prediction$27.08Low Prediction$27.08Holdings in SYNB have an aggregate price target of $27.08 and a range of $27.08 to $27.08 covering 33 companies (91.6% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy27 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 33 SYNB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.48%TMOThermo Fisher Scientific$469.88-3.9%4.8773 of 5 stars2.82$653.23 39.0%22Positive News5.74%ABBVAbbVie$201.31-1.9%4.4635 of 5 stars2.92$211.45 5.0%25Insider TradePositive NewsGap Up5.29%CTVACorteva$61.25-4.3%4.6384 of 5 stars2.72$68.06 11.1%18Analyst UpgradePositive NewsGap Down5.24%BIOBio-Rad Laboratories$234.89-4.3%4.2374 of 5 stars2.60$395.20 68.2%5Gap Down4.84%NVZMYNovozymes A/S$61.16+4.2%1.5845 of 5 stars3.003News Coverage4.45%LLYEli Lilly and Company$788.62-3.6%4.9213 of 5 stars2.84$1,009.72 28.0%194.35%AZNAstraZeneca$73.92+2.4%2.9551 of 5 stars3.10$89.75 21.4%10Positive NewsGap Up4.15%ASNDAscendis Pharma A/S$150.09-1.4%3.0525 of 5 stars2.93$204.64 36.3%144.10%NVDANVIDIA$101.80-7.8%4.9105 of 5 stars2.95$169.89 66.9%42Analyst DowngradeGap Down3.96%GOOGLAlphabet$150.72-4.0%4.5373 of 5 stars2.89$209.13 38.8%44Analyst ForecastInsider TradePositive NewsGap Down3.88%REGNRegeneron Pharmaceuticals$610.64-2.4%4.7624 of 5 stars2.76$966.88 58.3%25Analyst ForecastShort Interest ↑Analyst RevisionPositive News3.78%DDDuPont de Nemours$67.71-10.0%4.76 of 5 stars2.83$99.17 46.5%12Short Interest ↑News CoveragePositive NewsGap DownHigh Trading Volume2.95%CDNSCadence Design Systems$248.91-6.1%4.688 of 5 stars2.75$324.83 30.5%12Short Interest ↑Positive NewsGap Down2.81%AVTRAvantor$15.68-3.8%4.7412 of 5 stars2.77$25.50 62.6%13High Trading Volume2.75%DARDarling Ingredients$31.51-4.9%3.8785 of 5 stars2.88$52.75 67.4%8Analyst DowngradeOptions VolumePositive NewsGap Down2.53%NGVTIngevity$34.65-12.4%2.9731 of 5 stars2.67$55.17 59.2%6Positive NewsGap Up2.38%ICLRICON Public$163.60-3.0%4.4133 of 5 stars2.80$272.50 66.6%152.33%DHRDanaher$197.75-3.6%4.932 of 5 stars2.81$278.24 40.7%21Positive News1.95%ONONON$37.57-16.4%4.2646 of 5 stars2.96$60.45 60.9%24Analyst ForecastOptions VolumeNews CoverageGap DownHigh Trading Volume1.68%ARGXargenx$590.06+1.1%3.0644 of 5 stars2.91$687.00 16.4%23Positive NewsHigh Trading Volume1.68%BMRNBioMarin Pharmaceutical$67.48-1.2%4.9056 of 5 stars2.71$94.00 39.3%24Analyst DowngradeNews CoveragePositive News1.58%PPGPPG Industries$104.02-5.5%4.7734 of 5 stars2.47$137.77 32.5%15Analyst ForecastNews CoveragePositive NewsGap Down1.55%VRTXVertex Pharmaceuticals$484.01+0.1%3.7626 of 5 stars2.65$509.17 5.2%26Analyst ForecastPositive News1.33%TECHBio-Techne$54.86-6.0%4.8268 of 5 stars2.56$81.25 48.1%9Short Interest ↑Positive NewsGap Down1.12%ZTSZoetis$159.34-2.5%4.5464 of 5 stars3.08$215.90 35.5%12Positive News1.11%BIIBBiogen$130.71-0.5%4.8626 of 5 stars2.43$213.33 63.2%30Positive News1.07%ALNYAlnylam Pharmaceuticals$262.16-1.8%4.2828 of 5 stars2.77$316.25 20.6%26Analyst ForecastPositive News0.95%EXASExact Sciences$44.28-0.6%4.4222 of 5 stars2.90$70.26 58.7%210.95%TWSTTwist Bioscience$37.50-1.9%3.9551 of 5 stars2.70$54.10 44.3%10Positive NewsGap Down0.93%BGBunge Global$78.13+0.2%4.4768 of 5 stars2.60$93.00 19.0%5News CoveragePositive News0.64%LEGNLegend Biotech$32.88-1.1%2.6586 of 5 stars2.92$79.00 140.3%12Short Interest ↓Positive News0.62%RCKTRocket Pharmaceuticals$5.56-11.7%4.5092 of 5 stars2.92$43.00 673.4%12News CoveragePositive NewsHigh Trading Volume0.40%CRSPCRISPR Therapeutics$32.66-4.5%3.1697 of 5 stars2.48$73.11 123.8%21Gap Down This page (NYSEARCA:SYNB) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
